LAM can occur as an isolated disorder, defined as sporadic LAM or in patients with tuberous sclerosis complex, a genetic disease characterized by mutations of the TSC1 and TSC2 (Tuberous Sclerosis Complex) tumor suppressor genes respectively encoding hamartin and tuberin2. Here, TSC1 is linked to lymphangioleiomyomatosis.